Carl L.G. Hansen Ph.D.
Net Worth

Last updated:

What is Carl L.G. Hansen Ph.D. net worth?

The estimated net worth of Dr. Carl L.G. Hansen Ph.D. is at least $151,292,770 as of 25 Nov 2024. He owns shares worth $1,004,050 as insider, has earned $148,590,000 from insider trading and has received compensation worth at least $1,698,720 in AbCellera Biologics Inc..

What is the salary of Carl L.G. Hansen Ph.D.?

Dr. Carl L.G. Hansen Ph.D. salary is $424,680 per year as Chief Executive Officer, Pres & Chairperson in AbCellera Biologics Inc..

How old is Carl L.G. Hansen Ph.D.?

Dr. Carl L.G. Hansen Ph.D. is 51 years old, born in 1974.

What stocks does Carl L.G. Hansen Ph.D. currently own?

As insider, Dr. Carl L.G. Hansen Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
AbCellera Biologics Inc. (ABCL) Chief Executive Officer, Pres & Chairperson 233,500 $4.3 $1,004,050

What does AbCellera Biologics Inc. do?

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

ABCL logo
ABCL
AbCellera Biologics Inc.
$4.3

Carl L.G. Hansen Ph.D. insider trading

AbCellera Biologics Inc.

Dr. Carl L.G. Hansen Ph.D. has made only one insider trade between 2021-2024, according to the Form 4 filled with the SEC.

As of 25 Nov 2024 he still owns at least 233,500 units of ABCL stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Shares 56,125 $2.7 $151,538
Option
Share option (right to buy) 56,125 $2.7 $151,538
Option
Share option (right to buy) 56,125 $2.7 $151,538
Option
Common Shares 56,125 $2.7 $151,538
Option
Common Shares 56,125 $2.7 $151,538
Option
Share option (right to buy) 56,125 $2.7 $151,538
Option
Share option (right to buy) 56,125 $2.7 $151,538
Option
Common Shares 56,125 $2.7 $151,538
Option
Share option (right to buy) 56,125 $2.7 $151,538
Option
Common Shares 56,125 $2.7 $151,538
Option
Share option (right to buy) 56,125 $2.7 $151,538
Option
Common Shares 56,125 $2.7 $151,538
Option
Common Shares 56,125 $2.7 $151,538
Option
Share option (right to buy) 56,125 $2.7 $151,538
Option
Share option (right to buy) 56,125 $2.7 $151,538
Option
Common Shares 56,125 $2.7 $151,538
Option
Common Shares 56,125 $2.7 $151,538
Option
Share option (right to buy) 56,125 $2.7 $151,538
Option
Share option (right to buy) 56,125 $2.7 $151,538
Option
Common Shares 56,125 $2.7 $151,538
Option
Share option (right to buy) 56,125 $2.7 $151,538
Option
Common Shares 56,125 $2.7 $151,538
Option
Share option (right to buy) 56,125 $2.7 $151,538
Option
Common Shares 56,125 $2.7 $151,538
Option
Common Shares 224,500 $15.03 $3,374,235
Option
Share option (right to buy) 224,500 $2.7 $606,150
Sale
Common Shares 6,000,000 $24.77 $148,590,000

AbCellera Biologics key executives

AbCellera Biologics Inc. executives and other stock owners filed with the SEC: